James A Schoeneck - Net Worth and Insider Trading

James A Schoeneck Net Worth

The estimated net worth of James A Schoeneck is at least $50,522 dollars as of 2024-11-13. James A Schoeneck is the Director of FibroGen Inc and owns about 102,488 shares of FibroGen Inc (FGEN) stock worth over $39,314. James A Schoeneck is also the President and CEO of Assertio Holdings Inc and owns about 13,232 shares of Assertio Holdings Inc (ASRT) stock worth over $11,208. Details can be seen in James A Schoeneck's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James A Schoeneck has not made any transactions after 2023-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James A Schoeneck

To

James A Schoeneck Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James A Schoeneck owns 3 companies in total, including FibroGen Inc (FGEN) , AnaptysBio Inc (ANAB) , and First Light Acquisition Group Inc (FLAG) .

Click here to see the complete history of James A Schoeneck’s form 4 insider trades.

Insider Ownership Summary of James A Schoeneck

Ticker Comapny Transaction Date Type of Owner
FGEN FibroGen Inc 2023-06-07 director
ANAB AnaptysBio Inc 2017-01-25 director
FLAG First Light Acquisition Group Inc 2023-09-12 director

James A Schoeneck Latest Holdings Summary

James A Schoeneck currently owns a total of 2 stocks. Among these stocks, James A Schoeneck owns 102,488 shares of FibroGen Inc (FGEN) as of June 7, 2023, with a value of $39,314 and a weighting of 77.82%. James A Schoeneck also owns 13,232 shares of Assertio Holdings Inc (ASRT) as of December 2, 2014, with a value of $11,208 and a weighting of 22.18%.

Latest Holdings of James A Schoeneck

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FGEN FibroGen Inc 2023-06-07 102,488 0.38 39,314
ASRT Assertio Holdings Inc 2014-12-02 13,232 0.85 11,208

Holding Weightings of James A Schoeneck


James A Schoeneck Form 4 Trading Tracker

According to the SEC Form 4 filings, James A Schoeneck has made a total of 1 transactions in FibroGen Inc (FGEN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in FibroGen Inc is the sale of 7,100 shares on June 7, 2023, which brought James A Schoeneck around $128,013.

According to the SEC Form 4 filings, James A Schoeneck has made a total of 0 transactions in Assertio Holdings Inc (ASRT) over the past 5 years. The most-recent trade in Assertio Holdings Inc is the sale of 9,182 shares on December 2, 2014, which brought James A Schoeneck around $582,123.

Insider Trading History of James A Schoeneck

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James A Schoeneck Trading Performance

GuruFocus tracks the stock performance after each of James A Schoeneck's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James A Schoeneck is 6.47%. GuruFocus also compares James A Schoeneck's trading performance to market benchmark return within the same time period. The performance of stocks bought by James A Schoeneck within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James A Schoeneck's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James A Schoeneck

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.65 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 8.49 LIMIT LIMIT LIMIT LIMIT LIMIT

James A Schoeneck Ownership Network

Ownership Network List of James A Schoeneck

No Data

Ownership Network Relation of James A Schoeneck

Insider Network Chart

James A Schoeneck Owned Company Details

What does FibroGen Inc do?

Who are the key executives at FibroGen Inc?

James A Schoeneck is the director of FibroGen Inc. Other key executives at FibroGen Inc include Chief Commercial Officer Thane Wettig , director & Chief Executive Officer Enrique A Conterno , and SVP & China Operations Christine Chung .

FibroGen Inc (FGEN) Insider Trades Summary

Over the past 18 months, James A Schoeneck made 1 insider transaction in FibroGen Inc (FGEN) with a net sale of 7,100. Other recent insider transactions involving FibroGen Inc (FGEN) include a net purchase of 45,693 shares made by Thane Wettig , a net sale of 13,000 shares made by Jeffrey William Henderson , and a net sale of 16,133 shares made by Christine Chung .

In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 88,750 shares of FibroGen Inc (FGEN) were sold and 72,123 shares were bought by its insiders, resulting in a net sale of 16,627 shares.

FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

FibroGen Inc Insider Transactions

No Available Data

James A Schoeneck Mailing Address

Above is the net worth, insider trading, and ownership report for James A Schoeneck. You might contact James A Schoeneck via mailing address: C/o Depomed, Inc., 1360 O'brien Drive, Menlo Park Ca 94025.